Skip to main content

Table 1 Sociodemographic and clinical data of the study population

From: Comparative analysis of clinical symptoms and biochemical alterations in women with polycystic ovary syndrome: assessing the impact of type 1 diabetes versus non-diabetic controls

Variable

Non-diabetic controls (No. = 50)

Diabetic patients (No. = 50)

Test

P-value

Age (years)

 Mean ± SD

23.8 ± 5.2

23.3 ± 5.7

T

0.401

0.689

 Range (min–max)

16–37

15–38

   

Marital status, No. (%)

 Single

35 (70.0)

30 (60.0)

χ2

1.099

0.294

 Married

15 (30.0)

20 (40.0)

   

Have children

 Yes

10 (66.7)

11 (55.0)

 

0.486

0.486

 No

5 (33.3)

9 (45.0)

   

First delivery after marriage (years)

 Mean ± SD

1.2 ± 0.5

2.5 ± 1.9

χ2

2.197

0.049

Education, No. (%)

 University

35 (70.0)

19 (38.0)

χ2

9.698

0.021*

 Secondary

12 (24.0)

20 (40.0)

   

 Preparatory

1 (2.0)

8 (16.0)

   

 Primary

2 (4.0)

3 (6.0)

   

Employment, No. (%)

 Yes

17 (34.0)

6 (12.0)

χ2

6.832

0.009

 No

33 (66.0)

44 (88.0)

   

Family history of diabetes, No. (%)

 Yes

12 (24.0)

25 (50.0)

χ2

7.250

0.007

 No

38 (76.0)

25 (50.0)

   

Duration of diabetes (years)

 < 7

-

27 (54.0)

-

-

-

 7–14

 

13 (26.0)

   

 > 14

 

10 (20.0)

   

 Mean ± SD

 

7.8 ± 5.9

   

 Range (min–max)

 

1–22

   

Retinopathy, No. (%)

 Yes

9 (18.0)

10 (20.0)

χ2

0.065

0.799

 No

41 (82.0)

40 (80.0)

   

CVD, No. (%)

 Yes

1 (2.0)

3 (6.0)

χ2

0.260

0.610*

 No

49 (98.0)

47 (94.0)

   

Neuropathy, No. (%)

 Yes

4 (8.0)

7 (14.0)

χ2

0.409

0.522*

 No

46 (92.0)

43 (86.0)

   
  1. CVD cardiovascular disease, No. number, SD standard deviation. *P-value of χ2 (corrected) test, P < 0.05: significant, P > 0.05: not significant